Elevated Serum IL-17A but not IL-6 in Glioma Versus Meningioma and Schwannoma |
Doroudchi, Mehrnoosh
(Department of Immunology, School of Medicine, Shiraz University of Medical Sciences)
Pishe, Zahra Ghanaat (Shiraz University of Medical Sciences) Malekzadeh, Mahyar (Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences) Golmoghaddam, Hossein (Department of Immunology, School of Medicine, Shiraz University of Medical Sciences) Taghipour, Mousa (Shiraz University of Medical Sciences) Ghaderi, Abbas (Department of Immunology, School of Medicine, Shiraz University of Medical Sciences) |
1 | Benchetrit F, Ciree A, Vives V, et al (2002). Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood, 99, 2114-21. DOI |
2 | Alvarez-Rodriguez L, Lopez-Hoyos M, Munoz-Cacho P, Martinez-Taboada VM (2012). Aging is associated with circulating cytokine dysregulation. Cell Immunol, 273, 124-32. DOI ScienceOn |
3 | Arima T, Natsume A, Hatano H, et al (2005). Intraventricular chordoid meningioma presenting with Castleman disease due to overproduction of interleukin-6. Case report. J Neurosurg, 102, 733-7. DOI ScienceOn |
4 | Bondy ML, Scheurer ME, Malmer B, et al (2008). Brain tumor epidemiology consortium. brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer, 113, 1953-68. DOI ScienceOn |
5 | Damasceno M (2011). Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer. Curr Opin Oncol, 23, 3-9. DOI ScienceOn |
6 | Doroudchi M, Saidi M, Malekzadeh M, et al (2013). Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status. Future Oncol, 992, 295-304. |
7 | Gridley DS, Loredo LN, Slater JD, et al (1998). Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect Prev, 22, 20-9. DOI |
8 | Gutierrez C, Schiff R (2011). HER2: biology, detection, and clinical implications. Arch Pathol Lab Med, 135, 55-62. |
9 | Kantelhardt SR, Caarls W, de Vries AH, et al (2010). Specific visualization of glioma cells in living low-grade tumor tissue. PLoS One, 5, 11323. DOI ScienceOn |
10 | Hu J, Mao Y, Li M, Lu Y (2011). The profile of Th17 subset in glioma. Int Immunopharmacol, 11, 1173-9. DOI ScienceOn |
11 | Jarnicki A, Putoczki T, Ernst M (2010). Stat3: linking inflammation to epithelial cancer- more than a "gut" feeling? Cell Div, 5, 14. DOI ScienceOn |
12 | Jiang Y, Uhrbom L (2012). On the origin of glioma. Ups J Med Sci, 117, 113-21. DOI ScienceOn |
13 | Kryczek I, Wei S, Zou L, et al (2007). Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol, 178, 6730-3. DOI |
14 | Kujas M (1993). Meningioma. Curr Opin Neurol, 6, 882-7. DOI |
15 | Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44. DOI ScienceOn |
16 | Kumar R, Kamdar D, Madden L, et al (2006). Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncol Rep, 15, 1513-6. |
17 | Louis DN, Ohgaki H, Wiestler OD, et al (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114, 97-109. DOI |
18 | MacKenzie DJ (1926). A classification of the tumours of the glioma group on a histogenetic basis with a correlated study of prognosis. Can Med Assoc J, 16, 872. |
19 | Martin-Orozco N, Muranski P, Chung Y, et al (2009). T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity, 31, 787-98. DOI ScienceOn |
20 | Minniti G, Amichetti M, Enrici RM (2009). Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol, 4, 42. DOI ScienceOn |
21 | Martin-Villalba A, Okuducu AF, von Deimling A (2008). The evolution of our understanding on glioma. Brain Pathol, 18, 455-63. DOI ScienceOn |
22 | Merlo A, Juretic A, Zuber M, et al (1993). Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns. Eur J Cancer, 29, 2118-25. DOI ScienceOn |
23 | Michaud DS, Gallo V, Schlehofer B, et al (2010). Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev, 19, 2562-9. DOI ScienceOn |
24 | Miyahara Y, Odunsi K, Chen W, et al (2008). Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA, 105, 15505-10. DOI ScienceOn |
25 | Pfisterer WK, Hank NC, Preul MC, et al (2004). Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Neuro Oncol, 6, 290-9. DOI ScienceOn |
26 | Norden DA, Reardon AD, Wen YCP (2010). Primary central nervous system tumors: pathogenesis and therapy (Current Clinical Oncology). New York: Hummana: 2011 edition. |
27 | Numasaki M, Fukushi J, Ono M, et al (2003). Interleukin-17 promotes angiogenesis and tumor growth. Blood, 101, 2620-7. DOI ScienceOn |
28 | Park KJ, Kang SH, Chae YS, et al (2010). Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas. J Neurosurg, 112, 73-80. DOI ScienceOn |
29 | Pouratian N, Schiff D (2010). Management of low-grade glioma. Curr Neurol Neurosci Rep, 10, 224-31. DOI ScienceOn |
30 | Rittierodt M, Tschernig T, Samii M, et al (2001). Evidence of recurrent atypical meningioma with rhabdoid transformation and expression of pyrogenic cytokines in a child presenting with a marked acute-phase response: case report and review of the literature. J Neuroimmunol, 120, 129-37. DOI ScienceOn |
31 | Rahaman SO, Harbor PC, Chernova O, et al (2002). Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene, 21, 8404-13. DOI ScienceOn |
32 | Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G (2010). Molecular diagnostics of gliomas: state of the art. Acta Neuropathol, 120, 567-84. DOI |
33 | Sato T, Sugiyama T, Kawataki T, et al (2010). Clear cell meningioma causing Castleman syndrome in a child. J Neurosurg Pediatr, 5, 622-5. DOI ScienceOn |
34 | Sreekanthreddy P, Srinivasan H, Kumar DM, et al (2010). Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis. Cancer Epidemiol Biomarkers Prev, 19, 1409-22. DOI ScienceOn |
35 | Sfanos KS, Bruno TC, Maris CH, et al (2008). Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res, 14, 3254-61. DOI ScienceOn |
36 | Sherry MM, Reeves A, Wu JK, Cochran BH (2009). STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells, 27, 2383-92. DOI ScienceOn |
37 | Sim M, Dawson B, Landers G, et al (2013). Effect of exercise modality and intensity on post-exercise interleukin-6 and hepcidin levels. Int J Sport Nutr Exerc Metab, 23, 178-86. DOI |
38 | Wernicke AG, Dicker AP, Whiton M, et al (2010). Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma. Radiat Oncol, 5, 46. DOI ScienceOn |
39 | Tofaris GK, Patterson PH, Jessen KR, Mirsky R (2002). Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci, 22, 6696-703. |
40 | Van Meir E, Sawamura Y, Diserens AC, et al (1990). Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res, 50, 6683-8. |
41 | Wiemels J, Wrensch M, Claus EB (2010). Epidemiology and etiology of meningioma. J Neurooncol, 99, 307-14. DOI |
42 | Zhang B, Rong G, Wei H, et al (2008). The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun, 374, 533-7. DOI ScienceOn |
43 | Wang L, Yi T, Kortylewski M, et al (2009). IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med, 206, 1457-64. DOI ScienceOn |
44 | Zhang Y, Yu J, Qu L, Li Y (2012). Calcification of vestibular schwannoma: a case report and literature review. World J Surg Oncol, 10, 207. DOI |
45 | Zhou J, Tryggestad E, Wen Z, et al (2011). Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med, 17, 130-4. DOI ScienceOn |
46 | Fong B, Barkhoudarian G, Pezeshkian P, et al (2011). The molecular biology and novel treatments of vestibular schwannomas. J Neurosurg, 115, 906-14. DOI ScienceOn |
47 | Lee HK, Seo IA, Suh DJ, et al (2009). Interleukin-6 is required for the early induction of glial fibrillary acidic protein in Schwann cells during Wallerian degeneration. J Neurochem, 108, 776-86. DOI ScienceOn |
48 |
Reihmane D, Jurka A, Tretjakovs P, Dela F (2013). Increase in IL-6, TNF- |
![]() |